History

A list of downloadable documents created during development.

Background information

Final Appraisal Determination: Imatinib for chronic myeloid leukaemia

Appraisal Consultation Document: Imatinib for chronic myeloid leukaemia

Scope: Imatinib for Chronic Myeloid Leukaemia (first line therapy)

Protocol: The effectiveness and cost-effectiveness of imatinib for first line treatment of chronic myeloid leukaemia in chronic phase

Assessment Report: The effectiveness and cost-effectiveness of imatinib for first line treatment of chronic myeloid leukaemia in chronic phase